Cargando…

Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats

Ivermectin is a widely used antiparasitic drug with known efficacy against several single-strain RNA viruses. Recent data shows significant reduction of SARS-CoV-2 replication in vitro by ivermectin concentrations not achievable with safe doses orally. Inhaled therapy has been used with success for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaccour, Carlos, Abizanda, Gloria, Irigoyen-Barrio, Ángel, Casellas, Aina, Aldaz, Azucena, Martínez-Galán, Fernando, Hammann, Felix, Gil, Ana Gloria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555481/ https://www.ncbi.nlm.nih.gov/pubmed/33051517 http://dx.doi.org/10.1038/s41598-020-74084-y

Ejemplares similares

Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation
por: Chaccour, Carlos J., et al.
Publicado: (2018)

Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae
por: Chaccour, Carlos J., et al.
Publicado: (2017)

Screening for an ivermectin slow-release formulation suitable for malaria vector control
por: Chaccour, Carlos, et al.
Publicado: (2015)

Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
por: Chaccour, Carlos, et al.
Publicado: (2020)

Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
por: Chaccour, Carlos, et al.
Publicado: (2017)

Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes
por: Kern, Charlotte, et al.
Publicado: (2023)

The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes
por: Duthaler, Urs, et al.
Publicado: (2021)

Effectiveness of adjunctive nebulized antibiotics in critically ill patients with respiratory tract infections
por: Leache, Leire, et al.
Publicado: (2019)

Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study
por: Nicolas, Patricia, et al.
Publicado: (2021)

The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial
por: Chaccour, Carlos, et al.
Publicado: (2020)

Platelet Lysate Nebulization Protocol for the Treatment of COVID-19 and Its Sequels: Proof of Concept and Scientific Rationale
por: Beitia, Maider, et al.
Publicado: (2021)

Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis
por: Nicolas, Patricia, et al.
Publicado: (2020)

Effects of larval exposure to sublethal doses of ivermectin on adult fitness and susceptibility to ivermectin in Anopheles gambiae s.s.
por: Kiuru, Caroline, et al.
Publicado: (2023)

Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
por: Krolewiecki, Alejandro, et al.
Publicado: (2021)

Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway
por: Chaccour, Carlos, et al.
Publicado: (2017)

Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways
por: Chaccour, Carlos, et al.
Publicado: (2017)

The effect of ivermectin alone and in combination with cobicistat or elacridar in experimental Schistosoma mansoni infection in mice
por: Vicente, Belén, et al.
Publicado: (2021)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial
por: Mandro, Michel, et al.
Publicado: (2020)

BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings
por: Chaccour, Carlos, et al.
Publicado: (2023)

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial
por: Chowdary, Pratima, et al.
Publicado: (2023)

Proof-of-concept study for a long-acting formulation of ivermectin injected in cattle as a complementary malaria vector control tool
por: Pooda, Sié Hermann, et al.
Publicado: (2023)

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
por: Chaccour, Carlos, et al.
Publicado: (2021)

Treatment of Pregnant Women with Ivermectin during Mass Drug Distribution: Time to Investigate Its Safety and Potential Benefits
por: Erber, Astrid Christine, et al.
Publicado: (2021)

Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
por: Kern, Charlotte, et al.
Publicado: (2021)

Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study
por: Schöning, Verena, et al.
Publicado: (2022)

Inhibition of Plasmodium sporogonic stages by ivermectin and other avermectins
por: Azevedo, Raquel, et al.
Publicado: (2019)

Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination
por: Chaccour, Carlos J, et al.
Publicado: (2013)

Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]”
por: Krolewiecki, Alejandro, et al.
Publicado: (2021)

Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda
por: Chaccour, Carlos J, et al.
Publicado: (2015)

Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world
por: Nicholls, Rubén Santiago, et al.
Publicado: (2018)

Incidental mosquitocidal effect of an ivermectin mass drug administration on Anopheles farauti conducted for scabies control in the Solomon Islands
por: Kositz, Christian, et al.
Publicado: (2017)

Potential impact of 5 years of ivermectin mass drug administration on malaria outcomes in high burden countries
por: Marathe, Achla, et al.
Publicado: (2021)

Manual de farmacia clínica y atención farmacéutica /
por: Aldaz Pastor, Azucena

The Versatile Transceiver Proof of Concept
por: Troska, J, et al.
Publicado: (2009)

Nanosecond range electric pulse application as a non-viral gene delivery method: proof of concept
por: Ruzgys, Paulius, et al.
Publicado: (2018)

Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness
por: Walker, Martin, et al.
Publicado: (2017)

Cuproof: Range Proof with Constant Size
por: Deng, Cong, et al.
Publicado: (2022)

High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial
por: Buonfrate, Dora, et al.
Publicado: (2022)

Effect of IFN-α and other commonly used nebulization drugs in different nebulization methods on the resistance of breathing circuit filters under invasive mechanical ventilation
por: Jiang, Zhenjie, et al.
Publicado: (2022)

Assessing Muscle Fatigue in Multiple Sclerosis using the Sample Entropy of Electromyographic Signals: A Proof of Concept
por: Gomez-Hernández, Marina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cjte94ks8nip5r7rmdbmrpct7l